INS and metabolic dysfunction-associated steatotic liver disease: Rocha et al. conducted a study on NAFLD patients demonstrating that 98% of these patients were insulin resistant which is considered a landmark of MetS, while 39% of these patients were diabetic in addition to a marked increase in body mass index (BMI) and waist/hip ratio (24).